Loeffler Endocarditis Complicated by Cardiogenic Shock and Angioinvasive Fusarium fujikuroi Infection: A Case Report

Clicks: 10
ID: 328454
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #338 of 408 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 408 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Loeffler endocarditis is a form of restrictive cardiomyopathy that affects up to half of patients with hypereosinophilic syndromes. Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at increased risk of mixed cardiogenic and septic shock due to its restrictive ventricular physiology and treatment with immunosuppressive therapy. Case Summary A 64-year-old female with peripheral eosinophilia and heart failure with mildly reduced ejection fraction reported six months of fatigue, worsening lower extremity edema, palpitations, dyspnea on exertion, and orthopnea. She was diagnosed with Loeffler endocarditis based on cardiac magnetic resonance imaging and was initiated on high-dose prednisone and rituximab. While undergoing treatment of a subsequent angioinvasive fungal infection, she developed mixed cardiogenic and septic shock requiring inotropic support and broad-spectrum antimicrobials. She was eventually weaned off inotropic support and was continued on long-term posaconazole for the angioinvasive fungal infection. Discussion Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at an increased risk of mixed cardiogenic and septic shock. Late-stage Loeffler endocarditis predisposes to cardiogenic shock due to restrictive ventricular physiology and thrombi obliterating the ventricular cavities, while immunosuppressive therapy increases risk of opportunistic infections. If immunosuppression is initiated before ventricular fibrosis occurs, progression of Loeffler endocarditis can be halted or reversed.
Reference Key
openalex_W7212384214 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag670
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.